###begin article-title 0
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Synergistic activation of the human orphan nuclear receptor SHP gene promoter by basic helix-loop-helix protein E2A and orphan nuclear receptor SF-1
###end article-title 0
###begin p 1
###xml 95 112 95 112 <email xmlns:xlink="http://www.w3.org/1999/xlink">hsc@chonnam.ac.kr</email>
To whom correspondence should be addressed. Tel: +82 62 530 0503; Fax: +82 62 530 0500; Email: hsc@chonnam.ac.kr
###end p 1
###begin p 2
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 2
###begin p 3
###xml 322 325 318 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 499 502 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 633 636 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 638 642 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 712 716 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 829 832 825 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 970 974 966 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 984 991 980 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 996 1004 992 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1055 1059 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1151 1154 1147 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1218 1221 1214 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1319 1322 1315 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1419 1423 1415 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 627 632 <span type="species:ncbi:9606">human</span>
###xml 823 828 <span type="species:ncbi:10090">mouse</span>
###xml 1194 1199 <span type="species:ncbi:9606">human</span>
###xml 1212 1217 <span type="species:ncbi:10090">mouse</span>
###xml 1303 1308 <span type="species:ncbi:9606">human</span>
###xml 1313 1318 <span type="species:ncbi:10090">mouse</span>
The orphan nuclear receptor small heterodimer partner (SHP; NR0B2) is an unusual orphan nuclear receptor that lacks a conventional DNA-binding domain and acts as a modulator of transcriptional activities of a number of nuclear receptors. We have previously reported that the orphan nuclear receptor ERRgamma activates the SHP promoter. In this study, we have found that basic helix-loop-helix (bHLH) transcription factors, the E2A proteins (E47, E12 and E2/5), activated the human but not the mouse SHP promoter. In contrast, the tissue-specific E47 heterodimer partner BETA2 repressed the E47- mediated transactivation of the human SHP (hSHP) promoter. Using serial deletions and E-box mutant constructs of the hSHP promoter, we identified two E-boxes (E6 and E7) as E47-responsive E-boxes, which are not conserved in the mouse SHP promoter. Moreover, gel shift, chromatin immunoprecipitation (ChIP) and northern blot assays demonstrated that E47 directly binds to the hSHP promoter in vivo and in vitro and that Id proteins inhibited E47 binding to the hSHP promoter. Finally, we found that E47 and steroidogenic factor 1 (SF-1), a regulator of the SHP promoter, synergistically activate the human but not the mouse SHP promoter. Our findings suggest that the E2A proteins differentially regulate the human and mouse SHP promoters and cooperate with orphan nuclear receptor SF-1 for transcriptional activation of the hSHP promoter.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c1">1</xref>
###xml 608 609 608 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c2">2</xref>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c3">3</xref>
The nuclear receptor superfamily is a group of ligand-dependent transcriptional factors that usually contain two functionally independent and conserved domains (1). A conserved DNA-binding domain (DBD) allows them to associate directly with specific DNA response elements. A ligand-binding domain (LBD) is required for the binding of small lipophilic molecules, ligands or hormones, and for the transmission of ligand signals to transcriptional responses. The superfamily includes both conventional receptors with known ligands and orphan nuclear receptors that lack specific ligands [for reviews see Evans (2) and Giguere (3)].
###end p 5
###begin p 6
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c4">4</xref>
###xml 410 411 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c4">4</xref>
###xml 412 414 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c12">12</xref>
###xml 511 513 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c13">13</xref>
###xml 881 882 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c8">8</xref>
###xml 883 884 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c9">9</xref>
###xml 1018 1019 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c7">7</xref>
###xml 1020 1022 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c14">14</xref>
###xml 1029 1032 1013 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1076 1078 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c15">15</xref>
###xml 1085 1088 1069 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1211 1213 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c16">16</xref>
###xml 1214 1216 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c18">18</xref>
###xml 1250 1252 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c19">19</xref>
###xml 1266 1268 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c20">20</xref>
###xml 1278 1280 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c18">18</xref>
###xml 1296 1298 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c11">11</xref>
###xml 1477 1479 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c16">16</xref>
###xml 1480 1482 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c18">18</xref>
###xml 1502 1505 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1650 1656 1622 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A1</italic>
###xml 1935 1937 1907 1909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c21">21</xref>
###xml 1938 1940 1910 1912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c22">22</xref>
###xml 1991 1994 1963 1966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 2064 2066 2036 2038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c14">14</xref>
###xml 2003 2008 <span type="species:ncbi:9606">human</span>
SHP is one of unique members of the orphan nuclear receptor superfamily that lacks a conventional DBD, but contains a putative LBD (4). Various studies have reported that SHP is a repressor of transcriptional activities of a number of nuclear receptors, including both ligand-responsive receptors, such as ER, GR, TR, AR, RAR and RXR, and orphan receptors such as CAR, HNF4alpha, LRH-1, ERRgamma and LXRalpha (4-12). However, SHP was also found to be able to activate the transcriptional activity of PPARgamma (13). The very broad range of receptors sensitive to inhibition by SHP suggests a central role for SHP in modulation of nuclear receptor signaling pathways. Recent results demonstrate that SHP can compete with coactivators for binding to the AF-2 surface of nuclear receptors, and a direct transcriptional repression domain contributes to the inhibitory function of SHP (8,9). SHP is expressed in a wide variety of tissues, including heart, brain, liver, spleen, adrenal gland, small intestine and pancreas (7,14). The SHP gene consists of two exons and one intron (15), and SHP gene transcription is regulated by several members of the nuclear receptor superfamily, including bile acid receptor FXR (16-18), steroidogenic factor-1 (SF-1) (19), HNF4alpha (20), LRH-1 (18) and ERRgamma (11). Moreover, previous reports have suggested that SHP plays a pivotal role in the regulation of cholesterol homeostasis via a bile acid-activated regulatory cascade in the liver (16-18). The FXR-mediated SHP gene induction has been shown to inhibit the activity of orphan nuclear receptor LRH-1, a positive regulator of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression, which catalyzes the rate-limiting step in bile acid biosynthesis. However, loss-of-function studies of SHP demonstrated that redundant pathways independent of the SHP-mediated pathway are implicated in the negative feedback regulation of bile acid production (21,22). It has also been reported that mutations in the SHP gene in human are associated with mild hyperinsulinemia and obesity (14).
###end p 6
###begin p 7
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c23">23</xref>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c24">24</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c25">25</xref>
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c28">28</xref>
###xml 912 914 912 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ig</italic>
###xml 951 954 951 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 1014 1016 1014 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ig</italic>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c29">29</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c31">31</xref>
###xml 1086 1089 1086 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c32">32</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c33">33</xref>
###xml 1578 1580 1578 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c34">34</xref>
###xml 1581 1583 1581 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c38">38</xref>
Basic helix-loop-helix (bHLH) transcription factors comprise a large family of transcription factors, which bind to the specific DNA sequence CANNTG, known as the E-box [reviewed in Massari and Murre (23)]. The E2A proteins (E47, E12 and E2/5), encoded by the E2A gene, are the founder members of the vertebrate class I bHLH proteins (also called E proteins) (24). E2A proteins are all very similar; E12 and E47 proteins differ in their C-terminal bHLH sequences, whereas the differences between the E2/5 and E47 proteins are within their N-terminal sequences. A large body of evidence indicates that the E2A proteins play a central role in tissue-specific gene regulation, usually after their dimerization with tissue-specific class II bHLH proteins (25-28). Nevertheless, homodimers of E2A proteins are functionally active in B-cell lineages where they participate in the transcriptional regulation of several Ig genes. In fact, the products of the E2A gene (E12/E47) are required for B-cell differentiation and Ig gene rearrangements (29-31). In addition, targeted disruption of the E2A gene leads to thymic lymphomas, suggesting that E2A proteins can act as tumor suppressors (32). The transcriptional activity of E2A proteins can be negatively regulated by their dimerization with another subclass of HLH factors, the Id proteins (33). The four Id proteins, Id-1, Id-2, Id-3 and Id-4, identified thus far have only a HLH domain and lack the basic DNA-binding region. Dimerization of Id proteins with bHLH proteins results in the inhibition of DNA binding of bHLH proteins (34-38).
###end p 7
###begin p 8
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 445 448 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 761 765 761 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 898 902 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 912 919 912 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1030 1034 1030 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1076 1079 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 1131 1135 1131 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1238 1242 1238 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
The SHP promoter contains several E-box (CANNTG) sequences that are predicted to be bHLH protein response elements, and we investigated whether the bHLH protein subfamily members can regulate the SHP promoter. In this study, we demonstrated a preferential effect of E2A proteins (E47, E12 and E2/5) on the human but not the mouse SHP promoter. Detailed mapping studies revealed that only two (E6 and E7) of 13 E-box (CANNTG) motifs on the human SHP (hSHP) promoter are sufficient and necessary for the E47-mediated activation. Gel mobility shift assays and mutation studies confirmed the binding of E47 homodimers to the two E-boxes. In addition, Id-1, Id-2 and Id-3, known as inhibitory proteins of bHLH proteins, repressed E47-mediated transactivation of the hSHP promoter. Chromatin immunoprecipitation (ChIP) assay and northern blot analysis demonstrated that Id-2 inhibited E47 binding to the hSHP promoter in vivo and decreased hSHP expression. Furthermore, E47-mediated transactivation synergized with SF-1 to activate the hSHP promoter. These results suggest that the E2A gene products play a key role in the regulation of hSHP gene expression and cooperate with orphan nuclear receptor SF-1 for transcriptional activation of the hSHP promoter.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Plasmids and DNA construction
###end title 10
###begin p 11
###xml 363 364 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 526 530 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 728 732 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 995 999 991 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1361 1363 1357 1359 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CT</underline>
###xml 1433 1435 1429 1431 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CT</underline>
###xml 1508 1510 1504 1506 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CT</underline>
###xml 154 159 <span type="species:ncbi:9606">human</span>
The plasmids of CMV4-E47, E12 and E2/5 were kind gifts from Dr Roland Stein. pCMV5-casein kinase (CK) II-alpha was donated by Dr Michael P. Czech. pcDNA3-human Id-1, Id-2 and Id-3 were kind gifts from Dr John D. Norton. pCR3.1-BETA2 and RIPE3 (-126 to -86 bp) reporters that contain E-box elements from the insulin promoter were donated by Dr Ming-Jer Tsai. (523)4 Reporter plasmid that contains multiple E-boxes upstream of the luciferase gene was provided by Dr John Kim Choi. The wild-type and mutant reporter genes of the hSHP promoter were cloned into the pGL2-basic plasmid (Promega) vector using restriction enzymes and specific primers. Wild-type and serial deletion constructs containing 5'-flanking sequences from the hSHP promoter were fused to the luciferase gene at +30 (-2.2 kb/Luc, -1.35 kb/Luc, -574 bp/Luc, -355 bp/Luc, -330 bp/Luc, -280 bp/Luc, -263 bp/Luc, -250 bp/Luc, -243 bp/Luc, and deletion -574 to -243 bp/Luc). E-box mutant reporters (mE7, mE6, mE5 and mE6,7) from the hSHP promoter -2.2 kb/Luc were constructed by site-directed mutagenesis using the primers containing CA to AG substitution mutations in the core E-box (CANNTG) of individual E5, E6 and E7 E-boxes, and both E6 and E7 E-boxes. Mutations (underlined) were introduced using PCR with the following pairs of primers: mE7, 5'-CCTGCTGATTGTGCACCT-3' and 5'-AGGTGCACAATCAGCAGGCTTCCCCATTGGTGCCCG-3'; mE6, 5'-CCTGGGGCCTTGGTG-3' and 5'-CACCAAGGCCCCAGGCTCACAATCAGCAGG-3'; mE5, 5'-CTTGAGTCATCTGATAAG-3' and 5'-CTTATCAGATGACTCAAGCTGAT AAACAAGGTCATTAAC-3'. pcDNA3 hemagglutinin (HA)-E47, HA-SF-1, HA-LRH-1 and HA-ERRgamma were constructed by inserting EcoRI-, SalI- and XhoI-digested PCR products encoding the open reading frame of E47, SF-1, LRH-1 and ERRgamma into EcoRI- and XhoI-digested pcDNA3 HA vector.
###end p 11
###begin title 12
Cell culture and transient transfection assay
###end title 12
###begin p 13
###xml 260 261 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 487 491 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 647 650 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 130 136 <span type="species:ncbi:9913">bovine</span>
###xml 641 646 <span type="species:ncbi:10090">mouse</span>
###xml 994 997 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
HepG2, HeLa and CV-1 cells were maintained with Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL), supplemented with 10% fetal bovine serum (FBS; Biowhittaker) and antibiotics (Life Technologies). Cells were split in 24-well plates at densities of 2-20 x 104 cells/well the day before transfection. Transient transfections were performed using the SuperFect transfection reagent (Qiagen Inc.) according to the manufacturer's instructions. Cells were co-transfected with 0.2 microg of hSHP promoter wild-type, deletion constructs (-2.2 kb to -243 bp/Luc), E-box point mutant constructs (mE5/Luc, mE6/Luc, mE7/Luc and mE6,7), RIPE3/Luc and mouse SHP promoter (-2.2 kb/Luc) reporter plasmids together with 0.2 microg of pcDNA3 HA expression vectors for BETA2 and E47 and the indicated amounts of pCMV5-CK II-alpha, pcDNA3-hId-1, -2 and -3. Total DNA used in each transfection was adjusted to 1 microg/well by adding appropriate amount of pcDNA3 empty vector, and 0.2 microg of cytomegalovirus (CMV)-beta-galactosidase plasmids were co-transfected as an internal control. Cells were harvested approximately40- 48 h after the transfection for luciferase and beta-galactosidase assays. The luciferase activity was normalized by beta-galactosidase activity.
###end p 13
###begin title 14
Gel mobility shift assays
###end title 14
###begin p 15
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 127 129 127 129 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ag</underline>
###xml 235 241 235 241 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACCTG</underline>
###xml 250 256 250 256 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACCTG</underline>
###xml 278 284 278 284 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agCCTG</underline>
###xml 293 299 293 299 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACCTG</underline>
###xml 321 327 321 327 <underline xmlns:xlink="http://www.w3.org/1999/xlink">CACCTG</underline>
###xml 336 342 336 342 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agCCTG</underline>
###xml 370 376 370 376 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agCCTG</underline>
###xml 385 391 385 391 <underline xmlns:xlink="http://www.w3.org/1999/xlink">agCCTG</underline>
###xml 462 464 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 595 597 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c39">39</xref>
###xml 664 672 660 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 753 759 <span type="species:ncbi:9986">rabbit</span>
The probes used in gel shift assay cover the region -342 to -321 bp from the hSHP promoter. Mutated E-box sequences (CACCTG to agCCTG) in mE7, mE6 and mE6,7 are indicated in lower case in the following primers: E6,7 wild-type, 5'-GGGGACACCTGCTGATTGTGCACCTGGGGC-3'; mE7, 5'-GGGGAagCCTGCTGATTGTGCACCTGGGGC-3'; mE6, 5'-GGGGACACCTGCTGATTGTGagCCTGGGGC-3', and mE6,7, 5'-GGGGAagCCTGCTGATTGTGagCCTGGGGC-3'. Double-stranded oligonucleotides were end-labeled with [gamma-32P]ATP using T4 polynucleotide kinase. Bacterially expressed His-tagged E47 protein (His-E47) was purified as described previously (39), analyzed by SDS-PAGE and quantified by Coomassie blue staining. In vitro synthesized E47 and Id proteins were transcribed and translated using a coupled rabbit reticulocyte system (TNT, Promega) according to the manufacturer's instructions. Gel shift assays contained 10 mM Tris pH 8.0, 40 mM KCl, 0.05% NP-40, 6% glycerol, 1 mM dithiothreitol (DTT) and 1 microg of poly(dI-dC). A 1 microg aliquot of His-tagged E47 was mixed with 10 000 c.p.m. of end-labeled oligonucleotide probes in 20 microl of each reaction. After 20 min incubation, DNA-protein complexes were analyzed on a 4% polyacrylamide gel in 1x TBE (90 mM Tris, 90 mM boric acid, 2 mM EDTA). Gels were dried and analyzed by autoradiography.
###end p 15
###begin title 16
Chromatin immunoprecipitation (ChIP) assay
###end title 16
###begin p 17
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c40">40</xref>
###xml 619 623 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
The ChIP assay described by Shang et al. (40) was adopted, with modifications. HepG2 cells were transfected with 5 microg of pcDNA3 HA-E47 and pcDNA3-Id-2. Total DNA used in each transfection was adjusted to 10 microg/60 mm dish by adding appropriate amounts of pcDNA3 HA empty vector. The cells were fixed with formaldehyde 30 h after transfection and harvested. For immunoprecipitation, anti-HA antibodies (Roche Molecular Biochemicals) and protein A-Sepharose beads CL-4B (Amersham Biosciences) were used. The final DNA extractions were amplified using pairs of primers that cover the E47 response region within the hSHP promoter (nucleotides -120 to -474) 5'-CCCCTGGCAGGAATG-3' and 5'-AGGTTAGGCAAACAAGC-3').
###end p 17
###begin title 18
Northern blot analysis
###end title 18
###begin p 19
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c15">15</xref>
HepG2 cells were maintained in DMEM supplemented with 0.5% FBS for 24 h and changed to medium containing 20% FBS. Total RNA was isolated at 0, 1, 3, 6 and 12 h after 20% serum stimulation. Northern blot analysis was carried out as described previously (15).
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
Identification of E2A-encoded gene products as transcription factors regulating the hSHP promoter
###end title 21
###begin p 22
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f1">1</xref>
###xml 590 593 590 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 721 725 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 769 772 769 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 902 906 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 992 996 992 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1039 1040 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f1">1</xref>
###xml 1088 1091 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 1113 1117 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1242 1246 1242 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 1270 1274 1270 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 1386 1390 1386 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1406 1407 1406 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f1">1</xref>
###xml 1502 1506 1502 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1575 1579 1575 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1584 1588 1584 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 377 382 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
To identify the transcription factors that regulate the SHP promoter, we examined the nucleotide sequence of the hSHP promoter regions spanning from upstream -2.2 kb to downstream +10 bp of the putative transcription start site. Among the binding sites for various kinds of transcription factors in the hSHP promoter, we found 13 E-box (CANNTG) motifs (designated as E1-E13 in human), which are well known binding sites of bHLH transcription factors. We also aligned the mouse SHP (mSHP) promoter and found 11 E-boxes (Fig. 1A). To investigate whether bHLH protein members can regulate the SHP promoter, we performed a transient transfection assay using the reporter gene containing the -2.2 kb to +30 bp sequence of the hSHP promoter. We first examined the effects of E2A gene products (E2A proteins) including E47, E12 and E2/5, which belong to class I bHLH proteins (also called E proteins), on the hSHP promoter. Over-expression of E47, E12 and E2/5 in HepG2 cells strongly activated the hSHP promoter in a dose-dependent manner (Fig. 1B). In HeLa and CV-1 cells, a similar effect of E2A gene products on the hSHP promoter was observed (data not shown). Unexpectedly, over-expression of E47, E12 and E2/5 had no significant effect on the mSHP promoter, although the mSHP promoter also contains 11 potential E-boxes, indicating that E47-responsive regions may be present only in the hSHP promoter (Fig. 1C). Taken together, these results suggest that E2A proteins can be a positive regulator of the hSHP promoter and that E2A gene products can differentially regulate the hSHP and mSHP promoter.
###end p 22
###begin title 23
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
E2A gene products are sufficient for the transactivation of the hSHP promoter
###end title 23
###begin p 24
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c25">25</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c31">31</xref>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f2">2</xref>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f2">2</xref>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1058 1061 1058 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 1127 1131 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1266 1270 1266 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
It has been reported that E2A proteins are potent transcriptional activators as either homodimers or heterodimers (25-31). However, the transcriptional activity of E2A proteins as homodimers or heterodimers is highly specific for the enhancers they stimulate. To investigate whether E2A proteins function as either homodimers or heterodimers on the hSHP promoter, we tested the effect of class II bHLH proteins such as BETA2/NeuroD, MyoD and myogenin, which are heterodimer partners of E2A proteins. Interestingly, co-expression of BETA2 with E47 reduced the E47-mediated transactivation of the hSHP promoter, whereas overexpression of BETA2 alone had little effect on the basal activity in HepG2 or CV-1 cells (Fig. 2A). In contrast, BETA2 and E47 strongly activated the RIPE3 reporter that contains E-box elements from the insulin gene promoter, as previously reported (Fig. 2B). Other heterodimer partners of E47, such as MyoD and myogenin, also repressed the E47-mediated transactivation of the hSHP promoter (data not shown). These results suggest that E2A gene products alone may be sufficient for the transactivation of hSHP promoter, and heterodimerizatin of BETA2 with E2A may interfere with E47 homodimer formation or perhaps may even be repressive on the hSHP promoter.
###end p 24
###begin p 25
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c41">41</xref>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 660 664 660 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f2">2</xref>
It has been reported that CK II repressed the transcriptional activity of E47 homodimer by inhibiting DNA binding, while the transcriptional activity of E47 heterodimer is enhanced by CK II (41). To further confirm whether the activation of the hSHP promoter by E47 is due to E2A homodimers or heterodimers, we transiently transfected the CK II expression vector with or without E47 expression vector in HepG2 cells. Over-expression of CK II repressed the E47-dependent transactivation of the reporter gene in a dose-dependent manner, whereas CK II had no significant effect on the basal promoter activity, indicating that E47-dependent transactivation of the hSHP promoter may be mediated by E47 homodimers (Fig. 2C).
###end p 25
###begin title 26
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
Identification of two E-boxes (E6 and E7) as E47-responsive E-boxes on the hSHP promoter
###end title 26
###begin p 27
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 706 709 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 855 859 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 1052 1056 1052 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1385 1389 1385 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1550 1553 1550 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1657 1661 1657 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 685 690 <span type="species:ncbi:9606">human</span>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
###xml 702 705 <span type="species:ncbi:10116">rat</span>
In order to map the sequences required for E47-mediated activation, a series of 5' deletions of the hSHP promoter were used in a transient transfection assay. As shown in Figure 3A, E47 responsiveness was retained with a deletion up to -574 bp, but was lost with the -243 bp construct. In addition, a construct deleted from -574 to -243 within -2.2 kb of the hSHP promoter completely lost E47 responsiveness. These results indicate that the sequences required for E47 response lie in the region between -574 and -243, which contains five E-boxes (from E3 to E7). Notably, four (E3, E4, E6 and E7) out of the five E-boxes are unique to the hSHP promoter, while the E5 box is present in human, mouse and rat SHP promoters. To further identify E47-responsive E-boxes within this region (-574 to -243 bp), we made a series of E-box deletion constructs of the hSHP promoter as indicated in Figure 3B. In HepG2 and HeLa cells, E47 expression vectors were over-expressed together with the reporter genes driven by a series of E-box deletion constructs of the hSHP promoter. As shown in Figure 3C and D, E47-dependent activity of the hSHP promoter was still detected with further deletion up to -355 bp, which contains all seven E-boxes (E1-E7). However, the E47-mediated transactivity was markedly decreased by E7 deletion (-330 bp) and completely abolished by E6 deletion (-280 bp) from the hSHP promoter, although the -280 bp/Luc reporter contains five intact E-boxes (E1-E5). We could not observe E47-dependent activation of the further deletions of the SHP promoter, -263 bp, -250 bp and -243 bp/Luc. These results suggest that E47-dependent activation of the hSHP promoter is mediated through the -355 bp to -280 bp region containing the E6 and E7 E-boxes.
###end p 27
###begin p 28
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f4">4</xref>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f4">4</xref>
###xml 675 679 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 961 965 937 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1072 1073 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 1313 1317 1289 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1380 1384 1356 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 1523 1527 1499 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1594 1598 1570 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
The results from Figure 3C and D suggested that E47-dependent transactivation of the hSHP promoter may be directly mediated by E6 and E7 E-boxes. To address this, a serious of E-box mutants within the -2.2 kb hSHP promoter was constructed and transiently transfected with E47 expression vectors in HepG2 and HeLa cells. E-box mutant reporters were made by introducing CA to AG substitution mutations into the core E-box (CANNTG) of individual boxes E5, E6 and E7, and double mutation of both E6 and E7 E-boxes (Fig. 4A and B). As shown in Figure 4C and D, E47-mediated activity was markedly decreased with E7 mutation reporter (mE7/Luc), by approximately75% of the wild-type hSHP promoter activity. However, we observed a slight decrease in E47-mediated activity with mE6/Luc, by approximately30% of wild-type reporter activity. Notably, E47-mediated activity was completely abolished with the double E6 and E7 mutant reporter (mE6,7/Luc), although the -2.2 kb hSHP promoter still contains other intact E-boxes. This observation is consistent with the results from Figure 3C showing that E47-mediated transactivity was completely abolished by E6 and E7 deletion, although five E-boxes (E1-E5) were intact. As expected, the E47-mediated activity of the E5 box mutant (mE5/Luc) was similar to that of the wild-type hSHP promoter, in good agreement with the results showing that the mSHP promoter was not activated by E47 even though it contains the E5 E-box. Taken together, these results suggest that E47 transactivates the hSHP promoter through E-boxes E6 and E7, which are present only in the hSHP promoter.
###end p 28
###begin title 29
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
E47 directly binds to the E6 and E7 E-boxes on the hSHP promoter
###end title 29
###begin p 30
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f5">5</xref>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f5">5</xref>
###xml 948 949 948 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f5">5</xref>
###xml 1452 1456 1452 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1516 1517 1516 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f3">3</xref>
###xml 1519 1520 1519 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f4">4</xref>
###xml 1689 1693 1689 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
To further examine whether E47 directly binds to E6 and E7 E-boxes within the hSHP promoter, a series of gel mobility shift assays were conducted using oligonucleotides (-342 to -312 bp) containing wild-type, individual E6 and E7 E-box mutations (mE6, mE7) and a double E-box mutation (mE6,7) (Fig. 5A). Unexpectedly, only one band of E47-DNA complex was observed, although wild-type probes contain two E-boxes (E6 and E7). In addition, E47 bound to mE6 and mE7, but not mE6,7 double mutant probes, indicating that E47 may not bind to both E6 and E7 E-boxes simultaneously and either the E6 or the E7 E-box is required for E47 binding to the hSHP promoter (Fig. 5B). To determine to which E-box E47 binds with higher affinity, a series of competition assays were performed using 50- and 100-fold molar excess of unlabeled oligonucleotides of wild-type, mE6, mE7, mE6,7 and control probes from the insulin promoter E-box (RIPE3). As shown in Figure 5C, excess unlabeled oligonucleotides corresponding to wild type and mE6 greatly reduced the E47-DNA complex, while excess unlabeled mE7 oligonucleotides only marginally reduced the E47-DNA complex, indicating that E47 binds to the E7 E-box with higher affinity than to E6. As expected, mE6,7 had no significant effect on the E47-DNA complex, and RIPE3 control inhibited E47-DNA complex formation. These results are consistent with our previous observations showing that most of the transactivity of the hSHP promoter was decreased by E7 deletion or E7 mutation (Figs 3, 4C and D). Taken together, these data suggest that the E7 E-box is preferentially required for E47 binding, although both E-boxes are required for transactivation of the hSHP promoter and E47 can bind to either E-box (E6 or E7).
###end p 30
###begin title 31
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
Id family proteins repress the E47-dependent transactivation of the hSHP promoter
###end title 31
###begin p 32
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c30">30</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c34">34</xref>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f6">6</xref>
###xml 520 524 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f6">6</xref>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1070 1074 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1141 1145 1141 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1161 1162 1161 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f6">6</xref>
Id family proteins have been well documented to reduce E-box-mediated transactivation. Since Id proteins lack a DBD, dimerization of Id proteins with bHLH proteins results in the inhibition of DNA binding of bHLH proteins (30-34). To examine whether Id proteins can downregulate the hSHP promoter by repressing E47 activity, a transient transfection assay was performed with Id-1, Id-2, Id-3 and E47 expression vectors in HepG2 cells. As shown in Figure 6A, Id proteins inhibited E47-mediated transactivation of -355 bp hSHP reporter gene containing E6 and E7 E-boxes. However, we could not observe any specific inhibitory effect of Id proteins on the -243 bp reporter gene deleting E6 and E7 E-boxes (Fig. 6B). To investigate the effect of Id proteins on the DNA-binding activity of E47 to the hSHP promoter, a gel mobility shift assay was performed using the wild-type probe containing E6 and E7. As expected, a molar excess of Id proteins (Id-1, Id-2 and Id-3) reduced the E-box binding affinity of the E47 homodimer, suggesting that Id proteins repress E47-mediated hSHP promoter activity by inhibiting E47 binding to E-boxes within the hSHP promoter (Fig. 6C).
###end p 32
###begin p 33
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 460 461 460 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f7">7</xref>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 520 527 520 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 739 742 739 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 752 759 752 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 810 814 810 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 830 831 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f7">7</xref>
###xml 873 875 873 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id</italic>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c42">42</xref>
###xml 1051 1055 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1328 1331 1328 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1333 1337 1333 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id-2</italic>
###xml 1342 1345 1342 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E47</italic>
###xml 1377 1378 1377 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f7">7</xref>
###xml 1418 1422 1418 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Id-2</italic>
###xml 1680 1683 1680 1683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1768 1771 1768 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1911 1915 1911 1915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
To further investigate whether E47 binds to the hSHP promoter and Id proteins inhibit its binding in vivo, we performed a ChIP assay using the PCR primers specific for the -474 to -120 bp region of the hSHP promoter. In HepG2 cells, expression vector encoding HA epitope-tagged E47 was transfected alone or together with expression vector for Id-2, and cell lysates were immunoprecipitated with the specific antibody against the HA epitope. As shown in Figure 7A, HA-E47 formed a specific complex with the hSHP promoter in vivo and this interaction was diminished when Id-2 was co-expressed with HA-E47. No bands were observed from cells transfected with either empty vector or Id-2 alone. These results demonstrated that E47 binds to the SHP promoter in vivo and Id-2 reduced the E47 binding affinity for the hSHP promoter (Fig. 7A). Previously, it has been reported that Id gene expression is induced by serum stimulation and Id proteins are involved in cell cycle progression (42). Given that Id-2 can interfere with E47-mediated activation of the hSHP promoter, we surmized that inducing expression of endogenous Id-2 might reduce the expression of hSHP mRNA. To this end, total RNA was isolated from HepG2 cells at 0, 1, 3, 6 and 12 h after 20% serum stimulation, and northern blot analysis was performed using the cDNA of SHP, Id-2 and E47 as a probe. As shown in Figure 7B, the SHP mRNA level was reduced while Id-2 gene expression was increased by serum stimulation in a time-dependent manner. However, we could not detect any significant difference in E47 mRNA level by serum stimulation. This inverse relationship might be explained at least partly by the activation of SHP expression by E2A proteins, whose activities are inhibited by Id proteins, although SHP gene expression can be affected by serum stimulation through other factors. Taken together, these results suggest that Id proteins repress hSHP gene expression by interfering with E47 binding to E-boxes.
###end p 33
###begin title 34
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
Synergistic effects of SF-1 on the E47-medated transactivation of the hSHP promoter
###end title 34
###begin p 35
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 161 165 161 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 643 645 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c11">11</xref>
###xml 646 648 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c16">16</xref>
###xml 649 651 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c18">18</xref>
###xml 652 654 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c43">43</xref>
###xml 721 725 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 889 893 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 909 910 905 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
Based on the ChIP assay results showing that over-expressed E47 can bind to the hSHP promoter in vivo, we investigated whether endogenous E47 transactivates the hSHP promoter by comparing the basal promoter activities of wild-type hSHP promoter and mutant mE6,7/Luc reporter genes in HepG2 and CV-1 cells. As shown in Figure 8A, the basal promoter activity of mE6,7/Luc was drastically reduced to 35% of wild-type hSHP promoter activity, indicating that endogenous E47 may activate the hSHP promoter. It has been reported that the SHP promoter is regulated by several orphan nuclear receptors such as SF-1, FXR, LXR, LRH-1, ERRgamma and HNF4 (11,16-18,43). In addition, we found that SF-1-mediated transactivation of the hSHP promoter was also significantly decreased by E6 and E7 E-box mutation, suggesting that E47 might have a significant effect on the SF-1-dependent activation of the hSHP promoter (Fig. 8A).
###end p 35
###begin p 36
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 282 283 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
###xml 338 341 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 570 574 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 725 729 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 877 881 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1016 1020 1004 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1036 1037 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
###xml 1157 1161 1145 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1213 1214 1201 1202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1304 1305 1288 1289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1651 1652 1631 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
###xml 1815 1819 1795 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
To further investigate whether E47 cross-talks with the transcription factors that regulate the SHP promoter, a transient transfection assay was performed with expression vectors for FXR, LXR, SF-1 and ERRgamma together with E47 expression vectors in CV-1 cells. As shown in Figure 8B, E47-mediated transactivation of human but not mouse SHP promoter was enhanced synergistically by SF-1 and additively by ERRgamma. However, FXR, LXR and LRH-1 had no significant effects on the E47-mediated transactivation (data not shown). Interestingly, cooperative activation of the hSHP promoter by SF-1 and E47 was completely abolished, although SF-1 activated the mE6,7/Luc reporter gene with E47-responsive E-box mutations within the hSHP promoter. In addition, SF-1(DeltaAF2), an AF2 deletion mutant, neither activated nor synergistically augmented E47-mediated transactivation of the hSHP promoter, suggesting that the AF2 region of SF-1 is indispensable for both transactivation and synergistic activation with E47 of the hSHP promoter (Fig. 8C). To further investigate whether SF-1 binding to SF-1RE is required for the synergistic effect of E47 and SF-1 on the hSHP promoter, CV-1 cells were co-transfected with (523)4 luciferase reporter plasmids and expression vectors for E47, SF-1 and ERRgamma. The (523)4 luciferase reporter contains multiple E-boxes upstream of the luciferase gene and is specific for active homodimers of E47. The result showed that SF-1 and ERRgamma had no significant effects on the E47-mediated transactivation on the four-copy E-box luciferase reporter, indicating that SF-1 binding is essential for the synergy with E47 (Fig. 8D). Overall, these results demonstrated that binding to their responsive elements and the AF-2 domain of SF-1 are necessary for synergistic transactivation of the hSHP promoter by E47 and SF-1.
###end p 36
###begin title 37
DISCUSSION
###end title 37
###begin p 38
###xml 137 140 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 158 160 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c11">11</xref>
###xml 161 163 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c16">16</xref>
###xml 164 166 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c18">18</xref>
###xml 167 169 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c43">43</xref>
###xml 274 277 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 340 343 332 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 402 406 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 439 442 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 500 503 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 562 566 554 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 656 659 648 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 676 683 668 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 717 720 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 780 783 772 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 494 499 <span type="species:ncbi:10090">mouse</span>
Recent reports have identified several nuclear receptors, such as SF-1, LRH-1, HNF4, FXR, ERRgamma and LXRalpha, as potent regulators of SHP gene expression (11,16-18,43). However, it has not been fully characterized whether other families of transcription factors regulate SHP gene transcription. In this report, we have demonstrated that E2A gene products (E47, E12 and E2/5) are novel regulators of hSHP gene expression. Interestingly, E2A gene products regulate only the human, but not the mouse SHP promoter, and two E-boxes (E6 and E7) present only in the hSHP promoter are identified as E47-responsive E-boxes. Furthermore, Id proteins downregulate SHP gene expression in vivo by inhibiting E47 binding to the SHP promoter. This study may provide an important insight into SHP gene regulation and further into the cross-talk mechanisms of nuclear receptor function with bHLH and Id proteins.
###end p 38
###begin p 39
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c27">27</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c31">31</xref>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1199 1201 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c41">41</xref>
###xml 1312 1316 1312 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1400 1404 1400 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1420 1421 1420 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f5">5</xref>
###xml 1541 1545 1541 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
Transcription factors belonging to the bHLH family are known to regulate a variety of developmental programs, including myogenesis, neurogenesis, sex determination and hematopoiesis (27-31). Many of these processes are controlled by E protein homodimer or heterodimer composed of E proteins and tissue-specific bHLH factors such as BETA2, MyoD and myogenin. In this report, we have provided potential evidence that the hSHP promoter may be activated by E2A protein homodimers. First, we have shown that over-expression of E2A proteins alone is sufficient to transactivate the hSHP promoter in a couple of cell lines such as CV-1, HepG2 and HeLa cells, which originate from different tissues, i.e. kidney, liver and epithelium, respectively. We also observed that class II bHLH proteins, such as BETA2, myogenin and MyoD, inhibited the E2A protein-mediated transactivation of the hSHP promoter. These results suggest that tissue-specific class II bHLH proteins may not be required for this activation. In addition, it is reported that CK II acts as a positive regulator of myogenesis and a negative regulator of E protein homodimers by preventing E protein homodimers from binding to E-box elements (41). In good agreement with a previous report, we demonstrated that CK II downregulated E47 transactivity on the hSHP promoter, indicating that E47 homodimers may be involved in transactivation of the hSHP promoter (Fig. 5C). Overall, this evidence suggests that E2A proteins alone are sufficient and necessary for the transactivation of the hSHP gene, although it is still possible that other tissue-restricted bHLH proteins may be involved in this activation.
###end p 39
###begin p 40
###xml 88 93 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 148 153 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 229 234 221 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 297 302 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 309 311 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c44">44</xref>
###xml 383 388 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 465 468 445 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 518 523 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYP7A</italic>
###xml 576 580 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 659 662 635 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 673 675 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c43">43</xref>
###xml 708 711 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 756 759 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 892 895 868 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1195 1198 1171 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 1379 1386 1355 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1529 1531 1505 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c34">34</xref>
###xml 1532 1534 1508 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c38">38</xref>
###xml 1603 1607 1579 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1726 1730 1702 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1740 1744 1716 1720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mSHP</italic>
###xml 1777 1781 1753 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1791 1798 1767 1774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1803 1811 1779 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1818 1819 1794 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f6">6</xref>
###xml 1824 1825 1800 1801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f7">7</xref>
###xml 2123 2127 2099 2103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 2273 2277 2249 2253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 2486 2488 2462 2464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c25">25</xref>
###xml 2489 2491 2465 2467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c28">28</xref>
###xml 2492 2494 2468 2470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c34">34</xref>
###xml 2495 2497 2471 2473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c38">38</xref>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
###xml 144 147 <span type="species:ncbi:10116">rat</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 291 296 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 460 463 <span type="species:ncbi:10116">rat</span>
###xml 655 658 <span type="species:ncbi:10116">rat</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
###xml 1171 1176 <span type="species:ncbi:9606">human</span>
###xml 1189 1194 <span type="species:ncbi:10090">mouse</span>
It has been previously reported that ligands for nuclear receptor LXRalpha activate rat CYP7A gene expression via direct binding to LXRE on the rat CYP7A promoter. However, the LXRalpha-binding site is not conserved in the human CYP7A promoter and instead LXRalpha effectively represses the human CYP7A gene (44). Recently, it also has been demonstrated that the repression of human CYP7A gene expression by LXRalpha is due to LXRalpha-mediated human, but not rat, SHP gene induction, which is a negative regulator of CYP7A gene expression, suggesting that LXRalpha activates hSHP gene transcription by direct binding to LXRE that is not conserved in the rat SHP promoter (43). In this study, we showed that E2A gene products regulate human, but not mouse SHP gene expression via two E-boxes (E6 and E7) unique to the human gene promoter. These results suggest that E2A proteins may regulate SHP gene expression differentially among different species and, in turn, species-specific SHP expression may lead to its distinct functions in various species in an E2A protein-dependent manner. In addition, Id proteins downregulate the E protein-mediated transactivation of the human but not the mouse SHP gene. Therefore, we postulate that E2A proteins may indirectly regulate bile acid production, and bHLH proteins and Id proteins can be related to the function of nuclear receptors in vivo. It has been demonstrated that Id family proteins repress the transcriptional activity of bHLH proteins by blocking their binding to E-boxes (34-38). Therefore, we speculated that E47-mediated transactivation of the hSHP promoter might be reduced by Id proteins. Expectedly, Id-1, Id-2 and Id-3 repressed the E47-mediated transactivity of hSHP, but not mSHP, and reduced E47 binding to the hSHP promoter in vivo and in vitro (Figs 6 and 7). In addition, we demonstrated that SHP mRNA levels were decreased under conditions where Id-2 mRNA levels were increased by serum stimulation, although the E47 expression level showed no significant difference according to serum stimulation. These results suggested that Id proteins downregulate hSHP gene expression by repressing the E2A proteins. The notion that the ratio of E2A proteins to class II bHLH and Id proteins is a key regulator of hSHP gene expression is supported by the evidence that Id proteins and E2A heterodimer partners, such as class II bHLH proteins, are induced under specific physiological conditions or in a tissue-specific manner (25-28,34-38).
###end p 40
###begin p 41
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 88 90 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c11">11</xref>
###xml 91 93 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c19">19</xref>
###xml 171 175 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FSHR</italic>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c45">45</xref>
###xml 363 366 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 539 540 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkg906f8">8</xref>
###xml 609 613 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 683 687 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 845 849 841 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1381 1385 1377 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 1598 1601 1594 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
The current study demonstrates that the SHP promoter is regulated by SF-1 and ERRgamma (11,19). In addition, it has been reported that SF-1 regulates transcription of the FSHR gene via a mechanism that involves USF1 and USF2 binding to the proximal E-box element (45). Herein we demonstrated that E47 and SF-1 stimulate cooperatively the human, but not the mouse SHP promoter, supported by the results showing that mutations of the E6 and E7 E-boxes found only in the human promoter eliminated the synergistic effect by E47 and SF-1 (Fig. 8A and B). Interestingly, DNA binding by both E47 and SF-1 within the hSHP promoter is indispensable for the cooperative transactivation of the hSHP promoter. We also demonstrated the requirement for the AF2 region of SF-1 for both transactivation by SF-1 itself and synergistic activation with E47 of the hSHP promoter. This synergistic activation can be mediated by several mechanisms: (i) physical interaction between E47 and SF-1; (ii) recruitment of cofactors; and (iii) enhancement of their DNA binding. We observed that E47 directly interacted with SF-1 and that the A/B-DBDs of SF-1 are involved in the interaction with E47 in a GST pull-down assay (data not shown), suggesting that the synergistic activation can be mediated by direct interaction between them. However, the mechanism by which SF-1 and E47 cooperatively activate the hSHP promoter remains to be elucidated. The current results suggest that E47 and synergy with SF-1 could have important effects on a variety of nuclear receptor signaling pathways as a consequence of their effects on SHP.
###end p 41
###begin title 42
Figures and Tables
###end title 42
###begin p 43
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E2A</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 210 211 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 224 225 224 225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
E2A gene products of bHLH transcription factor activate the hSHP promoter. (A) Schematic diagrams of the human and mouse SHP promoter showing E-boxes. HepG2 cells were transfected with 200 ng of -2.2 kb human (B) and mouse (C) SHP promoter fused to a luciferase reporter, together with the indicated amount of expression vectors for E47, E12 or E2/5. Approximately 40 h after transfections, the cells were harvested and luciferase activity was measured and normalized against beta-galactosidase activity. One representative experiment is shown. All values represent the mean of duplicate samples, and similar results were obtained in at least three independent experiments. The representative results were expressed as fold activation (n-fold) over the value obtained with vector alone, with the error bars as indicated.
###end p 43
###begin p 44
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 225 226 225 226 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 348 349 348 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 E47 is sufficient for the transactivation of the hSHP promoter. (A) HepG2 (white bar) and CV-1 (black bar) cells were transfected with 200 ng of hSHP promoter reporter and expression vectors for E47 and BETA2 as indicated. (B) HepG2 cells were transfected with 200 ng of RIPE3 reporter gene and expression vectors for E47 and BETA2 as indicated. (C) HepG2 cells were transfected with 200 ng of hSHP/Luc and the indicated amount of the expression vectors for E47 and CK II. The luciferase activity was measured and normalized against beta-galactosidase activity. All values represent the mean of duplicate samples, and similar results were obtained in at least three independent experiments. The representative results were expressed as fold activation (n-fold) over the value obtained with vector alone, with the error bars as indicated.
###end p 44
###begin p 45
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 67 68 67 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 401 402 401 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 738 742 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 837 838 837 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 850 851 850 851 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
 Determination of the E47-responsive region on the hSHP promoter. (A) Schematic diagram of the hSHP promoter deletion constructs subcloned in pGL2-basic vector. The restriction enzymes used to make the deletions are indicated on the top. CV-1 cells were transfected with 200 ng of reporter plasmids containing serial deletion of the hSHP promoter and 200 ng of E47 expression vector or empty vector. (B) Illustration of serial E-box deletion constructs of the hSHP promoter. E-boxes (E7 to E3) in the hSHP promoter from -355 bp to +30 bp were serially deleted and subcloned into pGL2-basic vector by inserting the PCR fragments using various primers. Primers used to make the deletions are indicated on the top. E-boxes found in only the hSHP promoter are indicated in black boxes, and common E-boxes are indicated in gray boxes. HepG2 (C) and HeLa (D) cells were transfected with 200 ng of reporter plasmids and 200 ng of E47 expression vector or empty vector.
###end p 45
###begin p 46
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 155 156 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 267 268 267 268 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 280 281 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
 E6 and E7 E-boxes are responsible for E47-mediated activation of the hSHP promoter. (A) Schematic of mutated E-boxes within the hSHP (-2.2 kb) promoter. (B) Illustration of mutated E-box sequences, in each of which the sequence CANNTG was replaced by AGNNTG. HepG2 (C) and HeLa (D) cells were transfected with 200 ng of each mutated E-box, reporter plasmids and E47 expression vector or empty vector.
###end p 46
###begin p 47
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 53 54 53 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 266 267 266 267 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 400 401 400 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 708 711 <span type="species:ncbi:10116">rat</span>
 E47 binds to E6 and E7 boxes in the hSHP promoter. (A) Wild-type or mutated E-box probe sequences (-342 to -312 bp from the hSHP promoter) used in gel mobility shift assays. Mutated nucleotides (CACCTG to agCCTG) in mE6, mE7 and mE6,7 are indicated in lower case. (B) Purified His-E47 protein was incubated with end-labeled wild-type (WT) or mutated E-box (mE6, mE7 and mE6,7) probes as indicated. (C) Cold competition assay. Purified His-E47 protein (lanes 2-12) was incubated with end-labeled wild-type probe as indicated. In the cold competition assay, black right-angled triangles indicate 50- to 100-fold molar excess of each unlabeled probe as indicated, and con indicates the E-box probe from RIPE3 (rat insulin promoter element 3).
###end p 47
###begin p 48
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 333 334 330 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 336 338 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 395 399 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 428 436 425 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
 Id proteins inhibit E47-mediated transactivation of the hSHP promoter. HepG2 cells were transfected with 200 ng of hSHP (-355 bp)/Luc (A) and hSHP (-243 bp)/Luc (B), and 200 ng of expression vectors for E47, Id-1, Id-2 and Id-3 as indicated. The luciferase activity was measured and normalized against beta-galactosidase activity. (C) 32P-labeled DNA fragments containing E-boxes (E6,7) in the hSHP promoter were combined with in vitro transcribed and translated E47 and Id proteins as indicated. DNA-protein complexes were analyzed on a 4% polyacrylamide gel by autoradiography.
###end p 48
###begin p 49
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 85 86 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkg906c40">40</xref>
###xml 413 417 413 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 508 509 508 509 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 753 755 749 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
 Id-2 downregulates hSHP gene expression via repression of E47 DNA binding in vivo. (A) ChIP assay. HepG2 cells were transfected with HA/E47 and Id-2 expression vectors. Soluble chromatin from these cells was prepared and immunoprecipitated with monoclonal antibody against HA as described previously (40). The final DNA extractions were amplified using pairs of primers that cover the E47 response region of the hSHP promoter (forward primer, 5'-AGGTTAGGCAAACAA-3'; reverse primer, 5'-CCCCTGGCAGGAATG-3'). (B) Northern blot analysis of SHP, Id-2 and E47 after serum stimulation in HepG2 cells. Total RNA was isolated from HepG2 cells at 0, 1, 3, 6 and 12 h after 20% serum stimulation. An RNA blot containing 20 microg of total RNA was hybridized with 32P-labeled probes for SHP, Id-2 and E47 as indicated.
###end p 49
###begin p 50
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hSHP</italic>
###xml 269 270 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 462 463 458 459 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 513 516 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHP</italic>
###xml 677 678 669 670 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 685 686 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 465 470 <span type="species:ncbi:9606">Human</span>
 E47-mediated transactivation of the hSHP promoter is enhanced synergistically by SF-1 in CV-1 cells. (A) HepG2 and CV-1 cells were transfected with 200 ng of wild-type hSHP promoter reporter (-2.2 kb/Luc) or mE6,7/Luc together with pcDNA3 or SF-1 expression vectors. (B) CV-1 cells were co-transfected with 200 ng of human or mouse SHP promoter reporter (-2.2 kb) and 100 ng of expression vectors for E47 alone or together with SF-1 and ERRgamma as indicated. (C) Human wild-type or the E6,7 E-box mutant of the SHP promoter reporter (-2.2 kb) were co-transfected with 100 ng of expression vectors for E47, SF-1 wild type and AF2 deletion mutant (SF-1DeltaAF2) as indicated. (D) (523)4 Reporter plasmids that contain multiple E-boxes upstream of the luciferase gene were co-transfected with 100 ng of expression vectors for E47, SF-1 and ERRgamma as indicated. Two days after transfection, cells were harvested for luciferase and beta-galactosidase assays. The representative results were expressed as fold activation (n-fold) over the value obtained with vector alone, with the error bars as indicated.
###end p 50
###begin title 51
ACKNOWLEDGEMENTS
###end title 51
###begin p 52
We thank Drs Roland Stein, Michael P. Czech, John D. Norton and Ming-Jer Tsai for kind gifts of the plasmids, and Drs David D. Moore, Pyeung-Hyeun Kim and Kang-Yul Yoo for helpful advice and discussions and Dr Ming-Jer Tsai for critical reading. This work was supported by Korea Research Foundation Grant KRF-2000-015-DS0037 and in part by Hormone Research Center Grant HRC2001G0201.
###end p 52
###begin title 53
REFERENCES
###end title 53

